您的位置: 首页 > 农业专利 > 详情页

3-DISUBSTITUTED INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
专利权人:
SANOFI AVENTIS
发明人:
MARCO GIUSEPPE BARONI,LETIZIA PULEO
申请号:
FR0705858
公开号:
FR2920023B1
申请日:
2007.08.16
申请国别(地区):
FR
年份:
2013
代理人:
摘要:
Indol-2-one derivatives (I) and their acid or base addition salts, hydrates or solvates are new. Indol-2-one derivatives of formula (I) and their acid or base addition salts, hydrates or solvates are new. dotted line : simple or double bond; X : CH, N or C; Y1 : N or CH; Ar : aryl or heteroaryl (optionally substituted by one or more substituents comprising halo, alkoxy, aryl, perhaloalkyl or alkyl); R1 : H or -C(=O)alkyl, -C(=O)aryl or alkyl; R2-R4 : H, halo, alkyl, perhaloalkyl, CN, aryl, heteroaryl, OH, alkoxy, perhaloalkoxy, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl; R5 : alkyl; and n : 1 or 2. Provided that at least one of: X, Y1 is N; and R2-R4 are H. Independent claims are included for: (1) the preparations of (I); (2) a halo substituted indol-2-one compound of formula (III); (3) alkyl substituted 1,3-dihydro-indol-2-one compound of formula (XXVIII); and (4) a halo substituted indol-2-one compound of formula (XXIX). Hal, Hal2 : halo; and Alk : alkyl. [Image] [Image] ACTIVITY : Anorectic; Antidiabetic; Anorectic. MECHANISM OF ACTION : Growth hormone secretagogue receptor-1a antagonist. The ability of (I) to antagonize growth hormone secretagogue receptor-1a was tested in rats. The result showed that (+)N-[4,6-dichloro-3-(4-trifluoromethyl-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-2-(4-ethyl-piperidin-1-yl)-acetamide exhibited an IC 5 0value of 1x 10 ->; 9>;M.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充